Armistice Capital’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-70,083
Closed -$9.37M 258
2024
Q4
$9.37M Buy
70,083
+62,955
+883% +$8.97M 0.13% 98
2024
Q3
$930K Buy
+7,128
New +$879K 0.01% 173
2022
Q3
Sell
-348,492
Closed -$62.5K 220
2022
Q2
$62.5K Buy
348,492
+165,508
+90% +$42.3M 1.09% 22
2022
Q1
$62.2M Buy
182,984
+64,764
+55% +$21.9M 1.2% 20
2021
Q4
$43.8M Buy
118,220
+11,308
+11% +$4.28M 0.72% 37
2021
Q3
$42.2M Buy
106,912
+61,680
+136% +$28.4M 0.71% 37
2021
Q2
$20.8M Sell
45,232
-4,112
-8% -$1.66M 0.37% 66
2021
Q1
$18.4M Sell
49,344
-2,056
-4% -$838K 0.42% 60
2020
Q4
$18.5M Buy
+51,400
New +$16.4M 0.63% 48

Other funds holding ILMN

Armistice Capital's ILMN Position: Q1 2025 in Review

Armistice Capital sold out of Illumina (ILMN) in Q1 2025, closing a stake of 70,083 shares — an estimated $9.37M sold.

Armistice Capital first reported a position in ILMN in Q4 2020 and held it in 9 quarters. The position peaked at $62.2M in Q1 2022. 721 funds tracked by Wall St. Rank hold ILMN as of Q1 2025.

  • Armistice Capital reported no remaining Illumina position as of Q1 2025 after selling out during the quarter.
  • Armistice Capital sold 70,083 Illumina shares in Q1 2025, an estimated $9.37M.
  • Armistice Capital first reported a position in Illumina in Q4 2020 and held it in 9 quarters.
  • Armistice Capital's Illumina position peaked at $62.2M in Q1 2022.
  • 721 funds tracked by Wall St. Rank held Illumina as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.